Menu

  • Home
  • Books
    • Surviving Triple Negative Breast Cancer
    • The Magazine From Cover to Cover
    • Burn Scars: A Memoir of the Land and Its Loss
  • Blogs
    • East Spanish Peak
    • Positives About Negative
    • Psychology Today
  • Contact

Patricia Prijatel

Older Women with TNBC Benefit from Chemo

Patricia Prijatel

no comments

March 17, 2011

Some physicians contend that the risks of chemotherapy are greater than its benefits for older breast cancer patients; new research shows otherwise.

Women over 65 with triple-negative breast cancer with affected lymph nodes benefit from chemotherapy, according to research published in the Journal of the American Medical Association. Researchers surveyed the records of 6,487 women with lymph-node positive disease who were older than 65 and who had been treated between 1975 and 1999 with a variety of chemotherapy regimens. Their basic conclusion: Age alone should not be the determining factor in assessing treatment options.

“I believe older patients in generally good health with triple-negative disease should get the best possible chemotherapy,” said researcher Hyman Muss, MD, at the Miami Breast Cancer Conference. Muss is director of geriatric oncology at the University of North Carolina’s Lineberger Comprehensive Cancer Center, in Chapel Hill.

The Cancernetwork has an article on the research.

Share this:

  • Twitter
  • Facebook

Like this:

Like Loading...

Categories: Positives About Negative•

Leave a Reply Cancel reply

← Two April Teleconferences on TNBC
Journey into Spring: Celebrating Good Eggs →

Recent Posts

  • The Sacred Mountain
  • Clusters of P53 Protein Mutations Offer New Treatment Potentials for TNBC
  • Women Satisfied With "Going Flat" After Mastectomy
  • Looking for Research Participants in the UK on Building Resilience Online to Counter Psychological Effects of Breast Cancer

Archives

  • East Spanish Peak
  • Positives About Negative

Translate

  • LinkedIn
  • Facebook
  • Twitter

Go to mobile version
%d bloggers like this: